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Background: The association between statin use and risk of cancer development is controversial. Therefore, we conducted a nationwide 
population-based study to investigate this issue in Taiwan.
Methods: 29,863 patients who had received statins between 1998 and 2005 were included as the study group and compared with another 
29,854 age-, gender- and enrolled time-matched subjects who had not received statins as the comparison group. The end point was the 
development of any type of cancer before the end of 2007. The log-rank test was performed to analyze the differences in accumulated cancer-free 
survival rates between these two groups. Cox proportional hazard regressions were performed to evaluate the independent factors in determining 
longitudinal hazard of cancer.
Results: During the average 5.12 ± 2.8 years of follow-up, a total of 4321 patients of new cancer occurrence were observed: 1979 patients came 
from the study group and the other 2342 patients came from the comparison group. The log-rank test showed that the occurrence rate of newly 
diagnosed cancers in patients receiving statins was significantly lower than controls. (statins vs. controls: 6.6% vs. 7.8%, P<0.001), After adjusting 
for the patients’ age, gender, comorbidities, and use of fibrate, statins use was found to be independently associated with a lower risk for cancer 
occurrence (hazard ratio 0.89, 95% confidence interval 0.84 to 0.95, P<0.001).
Conclusions: Statin use is associated with less cancer occurrence in Taiwanese.
 
